Beauty Health (SKIN)
(Real Time Quote from BATS)
$1.56 USD
-0.08 (-4.88%)
Updated Sep 18, 2024 01:08 PM ET
4-Sell of 5 4
D Value B Growth F Momentum C VGM
Balance Sheet
Fiscal Year End for The Beauty Health Company falls in the month of December.
All items in Millions except Per Share data.
12/31/2023 | 12/31/2022 | 12/31/2021 | 12/31/2020 | 12/31/2019 | |
---|---|---|---|---|---|
Assets | |||||
Cash & Equivalents | 523 | 568 | 902 | 3 | 0 |
Receivables | 55 | 78 | 51 | 0 | 0 |
Notes Receivable | 0 | 0 | 0 | 0 | 0 |
Inventories | 91 | 116 | 35 | 0 | 0 |
Other Current Assets | 29 | 27 | 12 | 1 | 0 |
Total Current Assets | 698 | 789 | 1,001 | 4 | 0 |
Net Property & Equipment | 14 | 18 | 16 | 0 | 0 |
Investments & Advances | 0 | 0 | 0 | 460 | 0 |
Other Non-Current Assets | 0 | 0 | 0 | 0 | 0 |
Deferred Charges | 1 | 1 | 0 | 0 | 0 |
Intangibles | 188 | 171 | 180 | 0 | 0 |
Deposits & Other Assets | 16 | 14 | 7 | 0 | 0 |
Total Assets | 929 | 1,009 | 1,219 | 464 | 0 |
Liabilities & Shareholders Equity | 12/31/2023 | 12/31/2022 | 12/31/2021 | 12/31/2020 | 12/31/2019 |
---|---|---|---|---|---|
Notes Payable | 0 | 0 | 0 | 0 | 0 |
Accounts Payable | 45 | 30 | 29 | 0 | 0 |
Current Portion Long-Term Debt | 0 | 0 | 0 | 0 | 0 |
Current Portion Capital Leases | 0 | 0 | 0 | 0 | 0 |
Accrued Expenses | 42 | 37 | 43 | 1 | 0 |
Income Taxes Payable | 0 | 0 | 0 | 0 | 0 |
Other Current Liabilities | 24 | 1 | 0 | 0 | 0 |
Total Current Liabilities | 115 | 73 | 76 | 1 | 0 |
Mortgages | 0 | 0 | 0 | 0 | 0 |
Deferred Taxes/Income | 1 | 2 | 4 | 16 | 0 |
Convertible Debt | 738 | 734 | 730 | 0 | 0 |
Long-Term Debt | 0 | 0 | 0 | 0 | 0 |
Non-Current Capital Leases | 0 | 0 | 0 | 0 | 0 |
Other Non-Current Liabilities | 6 | 15 | 94 | 442 | 0 |
Minority Interest (Liabilities) | 0 | 0 | 0 | 0 | 0 |
Total Liabilities | 870 | 837 | 917 | 459 | 0 |
Shareholders Equity | 12/31/2023 | 12/31/2022 | 12/31/2021 | 12/31/2020 | 12/31/2019 |
---|---|---|---|---|---|
Preferred Stock | 0 | 0 | 0 | 0 | 0 |
Common Stock (Par) | 0 | 0 | 0 | 0 | 0 |
Capital Surplus | 541 | 550 | 722 | 6 | 0 |
Retained Earnings | -479 | -374 | -419 | -1 | 0 |
Other Equity | -3 | -5 | -1 | 0 | 0 |
Treasury Stock | 0 | 0 | 0 | 0 | 0 |
Total Shareholder's Equity | 59 | 171 | 302 | 5 | 0 |
Total Liabilities & Shareholder's Equity | 929 | 1,009 | 1,219 | 464 | 0 |
Total Common Equity | 59 | 171 | 302 | 5 | 0 |
Shares Outstanding | 122.90 | 132.20 | 149.60 | 57.50 | NA |
Book Value Per Share | 0.48 | 1.30 | 2.02 | 0.09 | 0.00 |
Fiscal Year End for The Beauty Health Company falls in the month of December.
All items in Millions except Per Share data.
6/30/2024 | 3/31/2024 | 12/31/2023 | 9/30/2023 | 6/30/2023 | |
---|---|---|---|---|---|
Assets | |||||
Cash & Equivalents | 350 | 445 | 523 | 559 | 550 |
Receivables | 42 | 49 | 55 | 68 | 80 |
Notes Receivable | 0 | 0 | 0 | 0 | 0 |
Inventories | 77 | 96 | 91 | 75 | 107 |
Other Current Assets | 21 | 26 | 29 | 36 | 31 |
Total Current Assets | 490 | 615 | 698 | 738 | 768 |
Net Property & Equipment | 10 | 12 | 14 | 16 | 18 |
Investments & Advances | 0 | 0 | 0 | 0 | 0 |
Other Non-Current Assets | 0 | 0 | 0 | 0 | 0 |
Deferred Charges | 3 | 2 | 1 | 1 | 1 |
Intangibles | 179 | 184 | 188 | 189 | 191 |
Deposits & Other Assets | 16 | 16 | 16 | 16 | 16 |
Total Assets | 712 | 845 | 929 | 973 | 1,007 |
Liabilities & Shareholders Equity | 6/30/2024 | 3/31/2024 | 12/31/2023 | 9/30/2023 | 6/30/2023 |
---|---|---|---|---|---|
Notes Payable | 0 | 0 | 0 | 0 | 0 |
Accounts Payable | 27 | 37 | 45 | 36 | 29 |
Current Portion Long-Term Debt | 0 | 0 | 0 | 0 | 0 |
Current Portion Capital Leases | 0 | 0 | 0 | 0 | 0 |
Accrued Expenses | 41 | 40 | 42 | 51 | 45 |
Income Taxes Payable | 0 | 0 | 0 | 0 | 0 |
Other Current Liabilities | 3 | 12 | 24 | 34 | 3 |
Total Current Liabilities | 75 | 94 | 115 | 126 | 83 |
Mortgages | 0 | 0 | 0 | 0 | 0 |
Deferred Taxes/Income | 1 | 1 | 1 | 2 | 2 |
Convertible Debt | 551 | 665 | 738 | 737 | 736 |
Long-Term Debt | 0 | 0 | 0 | 0 | 0 |
Non-Current Capital Leases | 0 | 0 | 0 | 0 | 0 |
Other Non-Current Liabilities | 3 | 6 | 8 | 14 | |
Minority Interest (Liabilities) | 0 | 0 | 0 | 0 | 0 |
Total Liabilities | 643 | 781 | 870 | 883 | 846 |
Shareholders Equity | 6/30/2024 | 3/31/2024 | 12/31/2023 | 9/30/2023 | 6/30/2023 |
---|---|---|---|---|---|
Preferred Stock | 0 | 0 | 0 | 0 | 0 |
Common Stock (Par) | 0 | 0 | 0 | 0 | 0 |
Capital Surplus | 553 | 547 | 541 | 565 | 561 |
Retained Earnings | -479 | -480 | -479 | -469 | -396 |
Other Equity | -5 | -4 | -3 | -5 | -4 |
Treasury Stock | 0 | 0 | 0 | 0 | 0 |
Total Shareholder's Equity | 69 | 63 | 59 | 90 | 162 |
Total Liabilities & Shareholder's Equity | 712 | 845 | 929 | 973 | 1,007 |
Total Common Equity | 69 | 63 | 59 | 90 | 162 |
Shares Outstanding | 123.90 | 123.40 | 122.90 | 132.50 | 132.80 |
Book Value Per Share | 0.56 | 0.51 | 0.48 | 0.68 | 1.22 |